Cyrus J. Lawrence’s Cardinal Health CAH Stock Holding History

Cyrus J. Lawrence’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-225	Closed	-$26K	–	66
2024 Q4	$26K	Buy	+225	New	+$26.3K	0.01%	141

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cyrus J. Lawrence's CAH Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 225 shares — an estimated $26K sold.

Cyrus J. Lawrence first reported a position in CAH in Q4 2024 and held it in 1 quarter. The position peaked at $26K in Q4 2024. 1,151 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

Cyrus J. Lawrence reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
Cyrus J. Lawrence sold 225 Cardinal Health shares in Q1 2025, an estimated $26K.
Cyrus J. Lawrence first reported a position in Cardinal Health in Q4 2024 and held it in 1 quarter.
Cyrus J. Lawrence's Cardinal Health position peaked at $26K in Q4 2024.
1,151 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.